4
Changes in Ownership
Anixa Biosciences Inc Filed Acc 0001513162-16-001082
Options or other derivatives
- Chief Financial Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Catelani Michael Chief Financial Officer | 2016-11-15 | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | D | ||
Loading xslF345X03/primary_doc.xml…